Your browser doesn't support javascript.
loading
Prospective randomized comparative study of the effect of pemafibrate add-on or double statin dose on small dense low-density lipoprotein-cholesterol in patients with type 2 diabetes and hypertriglyceridemia on statin therapy.
Hirano, Tsutomu; Hayashi, Toshiyuki; Sugita, Hiroe; Tamasawa, Atsuko; Goto, Satoshi; Tomoyasu, Masako; Yamamoto, Takeshi; Ohara, Makoto; Terasaki, Michishige; Kushima, Hideki; Ito, Yasuki; Yamagishi, Sho-Ichi; Mori, Yusaku.
Afiliação
  • Hirano T; Diabetes Center, Ebina General Hospital, Ebina, Japan.
  • Hayashi T; Division of Diabetes, Metabolism, and Endocrinology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.
  • Sugita H; Division of Diabetes, Metabolism, and Endocrinology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.
  • Tamasawa A; Yurakubashi Clinic, Tokyo, Japan.
  • Goto S; Division of Diabetes, Metabolism, and Endocrinology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.
  • Tomoyasu M; Asoka Hospital, Tokyo, Japan.
  • Yamamoto T; Division of Diabetes, Metabolism, and Endocrinology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.
  • Ohara M; Goto Iin, Nara, Japan.
  • Terasaki M; Division of Diabetes, Metabolism, and Endocrinology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.
  • Kushima H; Division of Diabetes, Metabolism, and Endocrinology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.
  • Ito Y; Division of Diabetes, Metabolism, and Endocrinology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.
  • Yamagishi SI; Division of Diabetes, Metabolism, and Endocrinology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.
  • Mori Y; Division of Diabetes, Metabolism, and Endocrinology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.
J Diabetes Investig ; 14(12): 1401-1411, 2023 Dec.
Article em En | MEDLINE | ID: mdl-37647503

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hipertrigliceridemia / Inibidores de Hidroximetilglutaril-CoA Redutases / Diabetes Mellitus Tipo 2 Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hipertrigliceridemia / Inibidores de Hidroximetilglutaril-CoA Redutases / Diabetes Mellitus Tipo 2 Idioma: En Ano de publicação: 2023 Tipo de documento: Article